We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVRI
9251
CALL
DELISTED
Everi Holdings
EVRI
$271K ﹤0.01%
20,500
-16,900
-45% -$240K
SKIN icon
9252
CALL
SkinHealth Systems
SKIN
$78.1M
$271K ﹤0.01%
45,000
-54,100
-55% -$380K
BKLN icon
9253
CALL
Invesco Senior Loan ETF
BKLN
$6.8B
$271K ﹤0.01%
12,900
-1,400
-10% -$29.5K
BTAI icon
9254
PUT
BioXcel Therapeutics
BTAI
$27.5M
$271K ﹤0.01%
6,688
+1,282
+24% +$130K
DRRX
9255
CALL
DELISTED
DURECT Corp
DRRX
$271K ﹤0.01%
108,700
+49,700
+84% +$169K
GGB icon
9256
PUT
Gerdau
GGB
$9.42B
$270K ﹤0.01%
68,022
-17,820
-21% -$79.2K
SCPH
9257
CALL
DELISTED
scPharmaceuticals
SCPH
$270K ﹤0.01%
37,900
-20,100
-35% -$158K
DBGR
9258
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
$269K ﹤0.01%
9,140
+1,320
+17% +$40K
HEAL
9259
Global X Funds Global X HealthTech ETF
HEAL
$31.2M
$269K ﹤0.01%
9,760
+1,061
+12% +$34K
GOOD
9260
CALL
Gladstone Commercial Corp
GOOD
$628M
$269K ﹤0.01%
22,100
-2,000
-8% -$26.2K
BIB icon
9261
CALL
ProShares Ultra NASDAQ Biotechnology
BIB
$90.1M
$269K ﹤0.01%
5,600
+300
+6% +$15.4K
MRGR icon
9262
ProShares Merger ETF
MRGR
$16M
$268K ﹤0.01%
6,756
-8,004
-54% -$313K
EBS icon
9263
PUT
Emergent Biosolutions
EBS
$231M
$268K ﹤0.01%
78,800
+37,600
+91% +$208K
MEME
9264
DELISTED
Roundhill MEME ETF
MEME
$268K ﹤0.01%
8,352
+2,503
+43% +$91.7K
BKSE icon
9265
BNY Mellon US Small Cap Core Equity ETF
BKSE
$91.5M
$268K ﹤0.01%
9,870
DFAR icon
9266
Dimensional US Real Estate ETF
DFAR
$1.77B
$268K ﹤0.01%
13,717
+3,619
+36% +$76.8K
SHE icon
9267
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$337M
$268K ﹤0.01%
+3,150
New +$279K
BKCC
9268
DELISTED
BlackRock Capital Investment Corporation
BKCC
$268K ﹤0.01%
72,137
+19,963
+38% +$71.7K
ZD icon
9269
PUT
Ziff Davis
ZD
$1.86B
$267K ﹤0.01%
4,200
+700
+20% +$48K
BF.A icon
9270
PUT
Brown-Forman Class A
BF.A
$12.9B
$267K ﹤0.01%
4,600
+2,900
+171% +$197K
PBTP icon
9271
Invesco 0-5 Yr US TIPS ETF
PBTP
$121M
$267K ﹤0.01%
+10,944
New +$268K
QVAL icon
9272
Alpha Architect US Quantitative Value ETF
QVAL
$613M
$267K ﹤0.01%
+7,200
New +$262K
YALA
9273
PUT
Yalla Group
YALA
$811M
$267K ﹤0.01%
50,900
+39,900
+363% +$203K
INST
9274
PUT
DELISTED
Instructure Holdings, Inc.
INST
$267K ﹤0.01%
10,500
-4,800
-31% -$124K
IUSB icon
9275
PUT
iShares Core Universal USD Bond ETF
IUSB
$43.3B
$267K ﹤0.01%
6,100
-600
-9% -$26.8K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.